Ahmedabad: Gujarat has attracted fresh investment of Rs 2,500-Rs 3,000 crore in pharmaceutical manufacturing after the state Food and Drugs Control Administration (FDCA) approved 59 new allopathic drug-making plants in the 2025-26 financial year. Officials said many of these upcoming facilities are being designed with export-ready infrastructure and are expected to deepen Gujarat’s role as…
Industry leaders say higher logistics costs are the new normal amid the West Asia conflict Instead of relying solely on sea routes through the Strait of Hormuz, some exporters are routing cargo via Sohar and Khor Fakkan ports and then using road networks to reach markets across the Gulf region Industry leaders say higher logistics…
Experts weigh in as Gujarat’s manufacturers face thinning margins amid US-Iran war Margins thin for Gujarat’s manufacturers as war rages on Experts weigh in as Gujarat’s manufacturers face thinning margins amid US-Iran war Margins thin for Gujarat’s manufacturers as war rages on Experts weigh in as Gujarat’s manufacturers face thinning margins amid US-Iran war For…
Ahmedabad: Retail prices of several non-scheduled medicines are expected to rise from July as pharmaceutical companies begin passing on higher input costs caused by a sharp increase in active pharmaceutical ingredient (API) prices owing to the West Asia conflict, industry officials said.Trade and industry representatives said prices of various APIs and bulk drugs have risen…
